NZ217322A - Toluidine derivatives and gastric acid inhibitor compositions - Google Patents
Toluidine derivatives and gastric acid inhibitor compositionsInfo
- Publication number
- NZ217322A NZ217322A NZ217322A NZ21732286A NZ217322A NZ 217322 A NZ217322 A NZ 217322A NZ 217322 A NZ217322 A NZ 217322A NZ 21732286 A NZ21732286 A NZ 21732286A NZ 217322 A NZ217322 A NZ 217322A
- Authority
- NZ
- New Zealand
- Prior art keywords
- gastric acid
- acid inhibitor
- inhibitor compositions
- toluidine derivatives
- toluidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853530342 DE3530342A1 (en) | 1985-08-24 | 1985-08-24 | Substituted toluidines, processes for their preparation, pharmaceutical preparations containing them and their use as gastric acid secretion inhibitors |
| DE19863610609 DE3610609A1 (en) | 1986-03-29 | 1986-03-29 | Substituted toluidines, processes for their preparation, pharmaceutical preparations containing them and their use as gastric secretion inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ217322A true NZ217322A (en) | 1990-02-26 |
Family
ID=25835350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ217322A NZ217322A (en) | 1985-08-24 | 1986-08-22 | Toluidine derivatives and gastric acid inhibitor compositions |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0213474B1 (en) |
| JP (1) | JPH0791276B2 (en) |
| KR (1) | KR940005020B1 (en) |
| AR (1) | AR243167A1 (en) |
| AT (1) | ATE85328T1 (en) |
| DE (1) | DE3687675D1 (en) |
| DK (1) | DK401586A (en) |
| ES (1) | ES2001389A6 (en) |
| FI (1) | FI89910C (en) |
| GR (1) | GR862180B (en) |
| HU (1) | HU199126B (en) |
| IE (1) | IE59587B1 (en) |
| IL (1) | IL79813A0 (en) |
| NO (1) | NO169169C (en) |
| NZ (1) | NZ217322A (en) |
| PH (1) | PH24073A (en) |
| PT (1) | PT83240B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR870008853A (en) * | 1986-03-28 | 1987-10-21 | 오쯔까 아끼히꼬 | Process for preparing hydroquinoline compound |
| EP0251536A1 (en) * | 1986-06-24 | 1988-01-07 | FISONS plc | Benzimidazoles, their production, formulation and use as gastric acid secretion inhibitors |
| IT1222412B (en) * | 1987-07-31 | 1990-09-05 | Chiesi Farma Spa | THYOMETHYL AND SULFINYL METHYL DERIVED WITH ANTI-SECRET ACID GASTRIC ACTION, THEIR PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US4957932A (en) * | 1987-11-25 | 1990-09-18 | Merck Frosst Canada, Inc. | Benzoheterazoles |
| EP0318085A3 (en) * | 1987-11-25 | 1990-03-14 | Merck Frosst Canada Inc. | Heterazole dialkanoic acids |
| JP2564162B2 (en) * | 1988-02-12 | 1996-12-18 | 日本ケミファ株式会社 | Quaternary salts of benzimidazole derivatives |
| ES2047451B1 (en) * | 1992-07-10 | 1994-10-01 | Sint Quimica Sa | PROCEDURE FOR THE PREPARATION OF A STABLE ORAL PHARMACEUTICAL COMPOSITION. |
| KR20040028815A (en) * | 2004-01-07 | 2004-04-03 | 화인고무(주) | Synthetic Leather that injection and heat adhension is available without using cement |
| CN115433167B (en) * | 2022-11-10 | 2023-03-24 | 中国药科大学 | Benzo-heterocyclic compound with Snail inhibitory activity, preparation method thereof, pharmaceutical composition and medical application |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE332167C (en) | 1918-08-09 | 1921-01-26 | Chem Fab Vorm Goldenberg | Glycerine substitute |
| BE788805A (en) | 1971-09-22 | 1973-01-02 | Lafon Victor | NEW ANTALGIC DERIVATIVES FROM THE SULFUR ARYLAMINE SERIES |
| SE416649B (en) | 1974-05-16 | 1981-01-26 | Haessle Ab | PROCEDURE FOR THE PREPARATION OF SUBSTANCES WHICH PREVENT Gastric acid secretion |
| SE7804231L (en) | 1978-04-14 | 1979-10-15 | Haessle Ab | Gastric acid secretion |
| US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| ZA825106B (en) * | 1981-08-13 | 1983-04-27 | Haessle Ab | Novel pharmaceutical compositions |
| US4472409A (en) | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
| DE3333314A1 (en) | 1983-09-15 | 1985-03-28 | Hoechst Ag, 6230 Frankfurt | SUBSTITUTED PYRIDO (1,2-C) IMIDAZO (1,2-A) BENZIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AND PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS |
| GB8417271D0 (en) * | 1984-07-06 | 1984-08-08 | Fisons Plc | Biologically active nitrogen heterocycles |
| DE3585252D1 (en) * | 1984-07-06 | 1992-03-05 | Fisons Plc | BENZIMIDAZOLES, AND METHOD FOR THE PRODUCTION THEREOF, THE FORMULATION AND USE THEREOF AS ANCIENT ANTI-ACIDIC COMPETITION. |
| AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
| DE3509333A1 (en) | 1985-03-15 | 1986-09-18 | Hoechst Ag, 6230 Frankfurt | SUBSTITUTED BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE AS AN INGESTIC ACID INHIBITOR |
| AU5768886A (en) * | 1985-05-24 | 1986-11-27 | G.D. Searle & Co. | 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines |
| WO1987001114A2 (en) * | 1985-08-21 | 1987-02-26 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New amines, process for their manufacture, their use and medicines containing them |
-
1986
- 1986-08-01 AR AR86305006A patent/AR243167A1/en active
- 1986-08-12 DE DE8686111104T patent/DE3687675D1/en not_active Expired - Fee Related
- 1986-08-12 EP EP86111104A patent/EP0213474B1/en not_active Expired - Lifetime
- 1986-08-12 AT AT86111104T patent/ATE85328T1/en not_active IP Right Cessation
- 1986-08-21 FI FI863382A patent/FI89910C/en not_active IP Right Cessation
- 1986-08-22 PH PH34172A patent/PH24073A/en unknown
- 1986-08-22 HU HU863659A patent/HU199126B/en not_active IP Right Cessation
- 1986-08-22 IL IL79813A patent/IL79813A0/en unknown
- 1986-08-22 ES ES8601270A patent/ES2001389A6/en not_active Expired
- 1986-08-22 NZ NZ217322A patent/NZ217322A/en unknown
- 1986-08-22 NO NO863389A patent/NO169169C/en unknown
- 1986-08-22 DK DK401586A patent/DK401586A/en not_active Application Discontinuation
- 1986-08-22 PT PT83240A patent/PT83240B/en not_active IP Right Cessation
- 1986-08-22 JP JP61195738A patent/JPH0791276B2/en not_active Expired - Lifetime
- 1986-08-22 GR GR862180A patent/GR862180B/en unknown
- 1986-08-22 IE IE225886A patent/IE59587B1/en not_active IP Right Cessation
- 1986-08-22 KR KR1019860006949A patent/KR940005020B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT44242A (en) | 1988-02-29 |
| AU595231B2 (en) | 1990-03-29 |
| PH24073A (en) | 1990-03-05 |
| FI863382A (en) | 1987-02-25 |
| NO169169B (en) | 1992-02-10 |
| AR243167A1 (en) | 1993-07-30 |
| DE3687675D1 (en) | 1993-03-18 |
| JPH0791276B2 (en) | 1995-10-04 |
| JPS6251671A (en) | 1987-03-06 |
| KR940005020B1 (en) | 1994-06-09 |
| IL79813A0 (en) | 1986-11-30 |
| ES2001389A6 (en) | 1988-05-16 |
| FI863382A0 (en) | 1986-08-21 |
| EP0213474B1 (en) | 1993-02-03 |
| EP0213474A3 (en) | 1987-05-20 |
| FI89910C (en) | 1993-12-10 |
| NO863389L (en) | 1987-02-25 |
| DK401586A (en) | 1987-02-25 |
| PT83240A (en) | 1986-09-01 |
| AU6174586A (en) | 1987-02-26 |
| DK401586D0 (en) | 1986-08-22 |
| GR862180B (en) | 1986-12-23 |
| HU199126B (en) | 1990-01-29 |
| EP0213474A2 (en) | 1987-03-11 |
| NO863389D0 (en) | 1986-08-22 |
| KR870002087A (en) | 1987-03-30 |
| PT83240B (en) | 1989-03-30 |
| NO169169C (en) | 1992-05-20 |
| ATE85328T1 (en) | 1993-02-15 |
| FI89910B (en) | 1993-08-31 |
| IE59587B1 (en) | 1994-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ216793A (en) | Phenethanolaminotetraline derivatives and pharmaceutical compositions | |
| ZA854684B (en) | Long-chain alpha-omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them | |
| NZ212415A (en) | 2-benzimidazolyl 2-pyridylmethylsulphide derivatives and pharmaceutical compositions | |
| NZ214998A (en) | 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions | |
| NZ217597A (en) | Urea derivatives and pharmaceutical compositions | |
| NZ216159A (en) | Thiene derivatives and yield-promoting compositions | |
| NZ218588A (en) | Benzoic acid derivatives and pharmaceutical compositions | |
| HU9202085D0 (en) | Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid | |
| NZ223079A (en) | 1h-imidazole-5-carboxylic acid derivatives and herbicidal compositions | |
| ZA891402B (en) | 4-amino-3-acyl qyuinoline derivatives and their use as inhibitors of gastric acid secretion | |
| IL85969A0 (en) | Ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
| NZ218428A (en) | Heterocyclically-substituted quinoline derivatives and pharmaceutical compositions | |
| NZ217078A (en) | N-piperidyl-benzamide derivatives and pharmaceutical compositions | |
| NZ217322A (en) | Toluidine derivatives and gastric acid inhibitor compositions | |
| IL86711A0 (en) | 5-pyrimidinecarboxamide derivatives and pharmaceutical compositions containing them | |
| NZ215587A (en) | 3-oxoandrost-4-ene-17beta-carboxylic acid ester derivatives and pharmaceutical compositions | |
| IL72157A (en) | 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them | |
| NZ218498A (en) | Fluoroalkylamine derivatives and pharmaceutical compositions | |
| NZ215273A (en) | N-(2-chloro-4-trifluoromethylphenyl)-3- trifluoromethylbenzenesulphonamide derivatives and fungicidal compositions | |
| NZ216720A (en) | Diazinylpiperidine derivatives and pharmaceutical compositions | |
| NZ216546A (en) | Glycerol derivatives and pharmaceutical compositions | |
| NZ224923A (en) | 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
| NZ217448A (en) | Xanthine derivatives and pharmaceutical compositions | |
| NZ215174A (en) | Barbituric acid derivatives and pharmaceutical compositions | |
| EP0191735A3 (en) | Novel oxaluric acid derivatives and pharmaceutical compositions containing them |